TNF and plasma cell myeloma: The role of TNF-α and IL-6 in the progression of myeloma cell growth, survival, angiogenesis, and osteoclastogenesis and the inhibition of osteoblast activity is well established, as well as their adverse prognostic significance in this hematological neoplasm [8, 26–30].